Top news of the week: 05.01.2021.
Startups
The Biotech Paradox of 2020: A Year In Review
2020 was an incredibly paradoxical year for those of us in biotech: the striking dichotomy of simultaneously experiencing agonizing tragedy alongside buoyant optimism. It was truly a ...
Massachusetts Next Generation Initiative
Program Overview The Massachusetts Next Generation Initiative (MassNextGen) is a five year, more than $2 million commitment to ensure greater gender parity in the next generation of life ...
Member Spotlight: Q&A with Forma Therapeutics
In January, we spoke with Frank Lee, CEO, Forma Therapeutics.
The Most Notable New Billionaires Of 2020
More than 200 newcomers joined the billionaires ranks in 2020 -- including the inventors of a fee-free stock trading app, the founders of a food delivery service and a 25-year-old ...
Nobel laureate Paul Krugman predicts a swift, sustained economic recovery once vaccines are rolled out
'I'm in the camp that expects rapid growth once people feel safe going out and spending money,' Nobel Prize-winning economist, Paul Krugman, said.
Calithera flunks phase 2 cancer trial, axes 35% of staff
A phase 2 clinical trial of Calithera Biosciences’ telaglenastat in renal cell carcinoma has missed its primary endpoint. The failure of the glutaminase inhibitor to improve ...
Breakingviews - Corona Capital: Icahn, Productivity, Natixis
Corona Capital is a column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.
Covid-19 news: Much of UK faces tighter restrictions as cases surge
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic